Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Analgesic strategies during extracorporeal shock wave lithotripsy
2014-001930-26Phase 4Active
- Sponsor
- Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
- Start
- Aug 2014
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of midazolam, fentanyl and dexketoprofen in nephrolithiasis (4 arms), sponsored by Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz. Primary endpoint: Primary efficacy endpoint. Started Aug 2014; status: active.
02
Drugs
midazolamfentanyldexketoprofen
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on 2014-001930-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001930-26.